Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK ...Middle East

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently at 60,000 liters of drug substance) and capabilities to support growing manufacturing programs...

Hence then, the article about samsung biologics expands u s manufacturing capabilities with strategic acquisition of human genome sciences from gsk was published today ( Monday 22/12/2025 - 01:46 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK )

Also on site :

• Manchester United vs Newcastle Prediction: Heavyweights Meet in Premier League’s Only Boxing Day Clash
• Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
• Maga’s biggest fear is coming true and Trump won’t survive it